CURE partnered with City of Hope for a webinar to discuss focusing on quality of life when talking with care teams during ...

In this on-demand webinar series, CURE partnered with City of Hope to discuss effective communication when making treatment ...

In this on-demand webinar series, CURE partnered with City of Hope to discuss how patients with breast cancer can best ...

Keytruda in early-stage triple-negative breast cancer led to immune-related adverse effects, including severe GI issues and ...

Colorectal cancer incidence is rising among adults under 55, despite overall declining rates since the mid-1980s. Lifestyle ...

Emotional support from friends significantly enhances resilience during cancer treatment, providing comfort and strength.

In patients with relapsed or refractory multiple myeloma, KRd56 and KRd27 showed similar effectiveness and safety, but other treatment options may be better. Receiving the once-weekly KRd56 treatment ...

Induction chemotherapy shows significant improvements for survival in patients with locally advanced cervical cancer.

The accelerated approval of Trodelvy for patients with metastatic urothelial cancer has been voluntarily withdrawn.

Expert answers to patients’ questions were offered as part of the CURE® Educated Patient® Prostate Cancer Summit.

The CAR-T cell therapy Carvykti has been shown to be effective among patients outside the confines of a clinical trial.

My quality of life has improved a lot after starting on a BTK inhibitor, but some things will never be the same — like being in crowded places without a mask!